-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNITYBIO RECEIVES FDA EXPANDED ACCESS AUTHORIZATION FOR LANDMARK TREATMENT OF LYMPHOPENIA WITH ANKTIVA®, THE CANCER BIOSHIELD™ PLATFORM, IN PATIENTS WITH SOLID TUMORS

Reuters·06/02/2025 13:00:02

Please log in to view news